tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Income Statement

Compare
429 Followers

Relay Therapeutics Income Statement

Last quarter (Q3 2024), Relay Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Relay Therapeutics's net income was $-88.11M. See Relay Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 25.55M$ 1.38M$ 3.03M$ 82.65M$ 0.00
Gross Profit
$ 20.28M$ -2.75M$ -896.00K$ 79.11M$ -2.85M
Operating Expenses
$ 398.55M$ 312.33M$ 230.04M$ 138.45M$ 84.05M
Depreciation and Amortization
$ 5.27M$ 4.13M$ 3.92M$ 3.55M$ 2.85M
EBITDA
$ -374.15M$ -306.82M$ -222.18M$ -52.25M$ -81.20M
Operating Income
$ -373.00M$ -299.27M$ -364.70M$ -55.80M$ -84.05M
Other Income/Expenses
$ 31.03M$ 8.77M$ 826.00K$ 3.38M$ 8.74M
Pretax Income
$ -341.97M$ -290.51M$ -363.87M$ -52.41M$ -75.31M
Net Income
$ -341.97M$ -254.26M$ -496.81M$ -49.01M$ -66.50M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.79$ -2.27$ -5.22$ -1.15$ -15.53
Diluted EPS
$ -2.79$ -2.27$ -5.22$ -1.15$ -15.53
Weighted Average Shares Outstanding
122.58M 112.23M 95.14M 42.62M 4.28M
Weighted Average Shares Outstanding (Diluted)
122.58M 112.23M 95.14M 42.62M 4.28M
Currency in USD

Relay Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis